JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mikita, T.
Right arrow Articles by Schindler, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mikita, T.
Right arrow Articles by Schindler, U.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 273, Issue 28, 17634-17642, July 10, 1998

Mutational Analysis of the STAT6 SH2 Domain

Thomas Mikita, Carla Daniel, Pengguang Wu, and Ulrike Schindler

From Tularik Inc., South San Francisco, California 94080

The SH2 domain of the STAT family of transcription factors is essential for STAT binding to phosphorylated cytoplasmic domains of activated cytokine receptors. Furthermore, the same domain mediates dimerization of activated STAT monomers, a prerequisite for DNA binding by this family of proteins. To identify amino acid residues within the STAT protein that mediate these various interactions, we have carried out an extensive mutational analysis of the Stat6 SH2 domain. Recombinant proteins carrying C-terminal deletions or double alanine substitutions were expressed in mammalian and insect cells and assayed for DNA binding, transcription activation, tyrosine phosphorylation, and the ability to interact with a tyrosine-phosphorylated peptide derived from the interleukin-4 receptor signaling chain. From these studies, we have identified amino acids that are required for both DNA binding and interleukin-4 receptor interaction, as well as residues that when mutated impair only one of the two functions. Our results suggest that the structural homology between the SH2 domain of Stat6 and that of the distantly related Src protein may be higher than predicted on the basis of primary amino acid sequence comparisons. However, the two types of SH2 domains may differ at their C-terminal ends.


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
X. Tang, D. L. Marciano, S. E. Leeman, and S. Amar
LPS induces the interaction of a transcription factor, LPS-induced TNF-{alpha} factor, and STAT6(B) with effects on multiple cytokines
PNAS, April 5, 2005; 102(14): 5132 - 5137.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. U. Lee and A. Rao
Molecular analysis of a locus control region in the T helper 2 cytokine gene cluster: A target for STAT6 but not GATA3
PNAS, November 9, 2004; 101(45): 16010 - 16015.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. Chen, M. O. Daines, and G. K. K. Hershey
Methylation of STAT6 Modulates STAT6 Phosphorylation, Nuclear Translocation, and DNA-Binding Activity
J. Immunol., June 1, 2004; 172(11): 6744 - 6750.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. A. Bruns, U. Schindler, and M. H. Kaplan
Expression of a Constitutively Active Stat6 In Vivo Alters Lymphocyte Homeostasis with Distinct Effects in T and B Cells
J. Immunol., April 1, 2003; 170(7): 3478 - 3487.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. M. Jensen, S. L. Meijer, R. A. Kurt, W. J. Urba, H.-M. Hu, and B. A. Fox
Regression of a Mammary Adenocarcinoma in STAT6-/- Mice Is Dependent on the Presence of STAT6-Reactive T Cells
J. Immunol., February 15, 2003; 170(4): 2014 - 2021.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. P. Andrews, M. B. Ericksen, C. M. Cunningham, M. O. Daines, and G. K. K. Hershey
Analysis of the Life Cycle of Stat6. CONTINUOUS CYCLING OF STAT6 IS REQUIRED FOR IL-4 SIGNALING
J. Biol. Chem., September 20, 2002; 277(39): 36563 - 36569.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Daniel, A. Salvekar, and U. Schindler
A Gain-of-function Mutation in STAT6
J. Biol. Chem., May 5, 2000; 275(19): 14255 - 14259.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Turkson, D. Ryan, J. S. Kim, Y. Zhang, Z. Chen, E. Haura, A. Laudano, S. Sebti, A. D. Hamilton, and R. Jove
Phosphotyrosyl Peptides Block Stat3-mediated DNA Binding Activity, Gene Regulation, and Cell Transformation
J. Biol. Chem., November 21, 2001; 276(48): 45443 - 45455.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.